EDWARD SWAILES: Open Payments
NPI 1184176133 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 27 payments from 10 companies in 2025. Trend: 2023 $136 · 2024 $514 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 4 | $132 |
| Ardelyx, Inc. | 4 | $84 |
| AKEBIA THERAPEUTICS INC | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 2 | $62 |
| Travere Therapeutics, Inc. | 4 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $19 |
Products named: TARPEYO, IBSRELA, Vafseo, JYNARQUE, BRILINTA, Kerendia, BENLYSTA, Wegovy.
Industry payments across NC — which companies pay providers there.
